Ausgabe 1/2011
Inhalt (39 Artikel)
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients
Maria Aparecida Nagai, Renê Gerhard, José Humberto T. G. Fregnani, Suely Nonogaki, Regina Barbosa Rierger, Mário Mourão Netto, Fernando A. Soares
RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways
Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Raza Ali, Shadan Ali, Sanjeev Banerjee, Fazlul H. Sarkar
The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells
Yan Lu, Hua Zhou, Wantao Chen, Yuexing Zhang, Anne W. Hamburger
A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk
Ke-Da Yu, Nan-Yan Rao, Ao-Xiang Chen, Lei Fan, Chen Yang, Zhi-Ming Shao
CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis
Abdulkader Albasri, Mohammed Aleskandarany, Ahmed Benhasouna, Desmond G. Powe, Ian O. Ellis, Mohammad Ilyas, Andrew R. Green
Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines
Stacy R. Millon, Julie H. Ostrander, J. Quincy Brown, Anita Raheja, Victoria L. Seewaldt, Nirmala Ramanujam
Role of ferritin alterations in human breast cancer cells
Svitlana I. Shpyleva, Volodymyr P. Tryndyak, Olga Kovalchuk, Athena Starlard-Davenport, Vasyl’ F. Chekhun, Frederick A. Beland, Igor P. Pogribny
Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration
Konstantin Koro, Stephen Parkin, Brant Pohorelic, An-Dao Yang, Aru Narendran, Cay Egan, Anthony Magliocco
Does radiotherapy planning without breath control compensate intra-fraction heart and its compartments’ movement?
Evrim Kadriye Tezcanli, Evren Ozan Goksel, Erdem Yildiz, Melahat Garipagaoglu, Öznur Şenkesen, Halil Kucucuk, Kazim Meriç Şengöz, Işik Aslay
Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer
Eun-Kyu Kim, Hyun-Ah Kim, Jae Soo Koh, Min Suk Kim, Kwan-Il Kim, Jong Inn Lee, Nan Mo Moon, Eunyoung Ko, Woo Chul Noh
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer
Nicholas J. Robert, Paul R. Conkling, Mark A. O’Rourke, Paul R. Kuefler, Kristi J. McIntyre, Feng Zhan, Lina Asmar, Yanping Wang, Oluwatoyin O. Shonukan, Joyce A. O’Shaughnessy
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)
A. Noske, S. Loibl, S. Darb-Esfahani, M. Roller, R. Kronenwett, B. M. Müller, J. Steffen, C. von Toerne, R. Wirtz, I. Baumann, G. Hoffmann, G. Heinrich, S. T. Grasshoff, H. U. Ulmer, C. Denkert, G. von Minckwitz
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia
Michal Konecny, Miriam Milly, Katarina Zavodna, Eva Weismanova, Jaroslava Gregorova, Iveta Mlkva, Denisa Ilencikova, Juraj Kausitz, Zdena Bartosova
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics
Elrasheid A. H. Kheirelseid, Hanzali Jumustafa, Nicola Miller, Catherine Curran, Karl Sweeney, Carmel Malone, Ray McLaughlin, John Newell, Michael J. Kerin
Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies
Pei-Hua Lu, Mu-Xin Wei, Shu-Ping Si, Xiao Liu, Wei Shen, Guo-Qing Tao, Min-Bin Chen
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study
Aditya Bardia, Janet E. Olson, Celine M. Vachon, DeAnn Lazovich, Robert A. Vierkant, Alice H. Wang, Paul J. Limburg, Kristin E. Anderson, James R. Cerhan
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study
Theodore M. Brasky, Matthew R. Bonner, Kirsten B. Moysich, Heather M. Ochs-Balcom, Catalin Marian, Christine B. Ambrosone, Jing Nie, Meng Hua Tao, Stephen B. Edge, Maurizio Trevisan, Peter G. Shields, Jo L. Freudenheim
Effects of breast cancer surgery and surgical side effects on body image over time
Karen Kadela Collins, Ying Liu, Mario Schootman, Rebecca Aft, Yan Yan, Grace Dean, Mark Eilers, Donna B. Jeffe
Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects
Min-Bin Chen, Xiao-Yang Wu, Wei Shen, Mu-Xin Wei, Chen Li, Bin Cai, Guo-Qing Tao, Pei-Hua Lu
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study
Shaheenah Dawood, Rong Hu, Michelle D. Homes, Laura C. Collins, Stuart J. Schnitt, James Connolly, Graham A. Colditz, Rulla M. Tamimi
Body weight and risk of breast cancer in BRCA1/2 mutation carriers
Peggy Manders, Anouk Pijpe, Maartje J. Hooning, Irma Kluijt, Hans F. A. Vasen, Nicoline Hoogerbrugge, Christi J. van Asperen, Hanne Meijers-Heijboer, Margreet G. E. M. Ausems, Theo A. van Os, Encarna B. Gomez-Garcia, Richard M. Brohet, Flora E. van Leeuwen, Matti A. Rookus
The RING heterodimer BRCA1–BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs
Apichart Atipairin, Bhutorn Canyuk, Adisorn Ratanaphan
Invasive ductal breast cancer associated polymyositis causing respiratory failure
Xi Li, Wanshou Qiu, Yong Huang, Juekun Wu, Renbin Liu
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin, Vuk Stambolic, Julie Lemieux, Bingshu E. Chen, Wendy R. Parulekar, Karen A. Gelmon, Dawn L. Hershman, Timothy J. Hobday, Jennifer A. Ligibel, Ingrid A. Mayer, Kathleen I. Pritchard, Timothy J. Whelan, Priya Rastogi, Lois E. Shepherd
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
Kelly-Anne Phillips, Julie Aldridge, Karin Ribi, Zhuoxin Sun, Alastair Thompson, Vernon Harvey, Beat Thürlimann, Fatima Cardoso, Olivia Pagani, Alan S. Coates, Aron Goldhirsch, Karen N. Price, Richard D. Gelber, Jürg Bernhard
Germline mutations in PALB2 in African-American breast cancer cases
Yuan Chun Ding, Linda Steele, Li-Hao Chu, Karen Kelley, Helen Davis, Esther M. John, Gail E. Tomlinson, Susan L. Neuhausen
Reversed urban–rural differences in breast cancer mortality (China, 2002–2008)
Min He, Qulian Guo, Guoqing Hu
No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women
Jonathan Beesley, Sharon E. Johnatty, Xiaoqing Chen, Amanda B. Spurdle, Paolo Peterlongo, Monica Barile, Valeria Pensotti, Siranoush Manoukian, Paolo Radice, Georgia Chenevix-Trench
Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast
Eugeni Lopez-Bonet, Maria Carmen Pérez-Martínez, Begoña Martin-Castillo, Miguel Alonso-Ruano, Francesc Tuca, Cristina Oliveras-Ferraros, Sílvia Cufí, Alejandro Vazquez-Martin, Miquel Beltràn, Luis Bernadó, Javier A. Menendez
A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis
Pei-Hua Lu, Min-Bin Chen, Mu-Xin Wei, Zhi-Yang Jiang, Chen Li
Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: appraisal of a recent meta-analysis
Ping Zhou, Jian-Ping Li, Chun Zhang
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population
Chun Zhang, Ping Zhou, Jian-Ping Li
Effects of breast cancer surgery and surgical side effects on body image over time
Alexandre Mendonça Munhoz, Rolf Gemperli, José Roberto Filassi
Effects of breast cancer surgery and surgical side effects on body image over time
Karen Kadela Collins, Maria Pérez, Mario Schootman, Rebecca Aft, Donna B. Jeffe
New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk
Pei-Hua Lu, Min-Bin Chen, Wei Shen, Chen Li, Ming-Yu Wu, Guo-Qing Tao
Erratum to: A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
Steven Sugarman, Carolyn Wasserheit, Elizabeth Hodgman, Maryellen Coglianese, Anne D’Alassandro, Monica Fornier, Tiffany Troso-Sandoval, Gabriella D’Andrea, Pamela Drullinsky, Diana Lake, Roshini George, Nancy Mills, Maryellen Moynahan, Joyce Smith, Katherine Panageas, Larry Norton, Clifford Hudis
Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
Anita L. Bane, Dushanthi Pinnaduwage, Sarah Colby, Michael Reedijk, Sean E. Egan, Shelley B. Bull, Frances P. O’Malley, Irene L. Andrulis
Erratum to: The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
Felice A. Tager, Paula S. McKinley, Freya R. Schnabel, Mahmoud El-Tamer, Ying Keun K. Cheung, Yixin Fang, Claire R. Golden, Margery E. Frosch, Ulya Habif, Margaret M. Mulligan, Ivy S. Chen, Dawn L. Hershman